CONMED Corporation Announces Retirement of Chief Financial Officer
November 02 2017 - 4:01PM
Business Wire
CONMED Corporation (NASDAQ: CNMD) today announced that
Luke A. Pomilio, Executive Vice President, Finance and Chief
Financial Officer, has decided to retire after over two decades of
service with the Company.
The Company has initiated a search for a new CFO. In order to
ensure an orderly transition, Mr. Pomilio is committed to remaining
in his current role until a successor is found.
Curt R. Hartman, CONMED’s President and Chief
Executive Officer, said, “On behalf of the Board and the entire
CONMED team, I would like to thank Luke for his invaluable
contributions to the improvement of the Company’s commercial
execution, to the development of our financial organization, and to
CONMED as a whole. We appreciate his commitment to our Company and
its shareholders during his distinguished career here, and we wish
him the very best as he transitions into retirement.”
Luke A. Pomilio, Executive Vice President, Finance and Chief
Financial Officer, commented, “I have been honored to be a part of
the CONMED team for the last two decades and to lead its finance
team for the past several years. I am proud of the progress we have
made in strengthening the Company’s profile, and I am confident
that CONMED is well positioned for growth and success.”
Mr. Pomilio was appointed CONMED’s Chief Financial Officer on
April 1, 2015. He joined the Company as Controller in September
1995 and, subsequently, assumed additional responsibilities for
certain corporate functions including worldwide operations and
select administrative functions. In May 2009, he was promoted to
Vice President, Controller and Corporate General Manager. Prior to
joining CONMED, Mr. Pomilio was employed as a manager with Price
Waterhouse LLP.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery and gastroenterology. CONMED has a direct selling
presence in 17 countries, and international sales constitute
approximately 50% of the Company’s total sales. Headquartered in
Utica, New York, the Company employs approximately 3,300 people.
For more information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2016.
Any and all forward-looking statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995 and relate to the Company’s performance on a
going-forward basis. The Company believes that all forward-looking
statements made by it have a reasonable basis, but there can be no
assurance that management’s expectations, beliefs or projections as
expressed in the forward-looking statements will actually occur or
prove to be correct.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171102006552/en/
CONMED CorporationLuke A. Pomilio,
315-624-3202Chief Financial Officer
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Apr 2023 to Apr 2024